CARE&GO: Alfasigma's tips for summer!
CARE&GO is Alfasigma's innovative summer social campaign, which will accompany travelers during the summer period, giving advice easy to put into practice everyday....
Read moreCARE&GO is Alfasigma's innovative summer social campaign, which will accompany travelers during the summer period, giving advice easy to put into practice everyday....
Read moreAhead of World Digestive Health 2022, Italian pharmaceutical group Alfasigma is proud to announce the launch of its new diagnostic drug Lumeblue™ (per-oral methylene blue). This latest innovation is...
Read moreAmong the top 10 also A_MAB in the HR category. To Alfathon goes the Best PR & Communication project....
Read moreNew EVF Guidelines publication entitled Management of CVD of lower limbs – Part II reports Sulodexide scientific evidences in the dedicated chapter to Prevention of Post-Thrombotic Syndrome, definin...
Read moreInnovation Pharmaceuticals announces License Agreement with Alfasigma S.p.A. for the development and commercialization of Brilacidin in Ulcerative Proctitis/Ulcerative Proctosigmoiditis....
Read moreAlfasigma USA has acquired the brand ZELNORM (tegaserod), a treatment for IBS-C, from Sloan Pharma, with the aim to relaunch the brand in the United States....
Read moreYou’re entering Alfasigma global website
I agree